skip to content

Cambridge Immunology Network

 

Vice-Chancellor’s awards showcase impact and engagement during the pandemic

6 October 2020

Academics, students and professional members of staff from across the University have been recognised in this year’s Vice-Chancellor’s Research Impact and Engagement Awards for their work in areas including COVID-19 testing, PPE production and online engagement. Read the original article here>

Read more

Cambridge researcher named to Time 100 list of world's most influential people

23 September 2020

Professor Ravi Gupta has been named today as one of Time Magazine’s 100 Most Influential People of the Year , in recognition of his work to bring about the second-ever cure of a patient with HIV. In 2019, the case of ‘ The London Patient ’ made global headlines, as 40-year-old Adam Castillejo underwent a bone marrow...

Read more

COVID-19: What to expect from a vaccine. By Professor Gordon Dougan

11 September 2020

One of the hottest topics around COVID-19 is the need for a vaccine for this new disease, which has had a huge impact on both human health and economies. The disease caught most people completely by surprise and shows no signs of disappearing naturally. In many ways the consideration of health and economics form the two...

Read more

New model predicts oesophageal cancer eight years early for half of all patients

7 September 2020

DNA from tissue biopsies taken from patients with Barrett’s oesophagus – a risk factor for oesophageal cancer – could show which patients are most likely to develop the disease eight years before diagnosis, suggests a study led by researchers at the University of Cambridge and EMBL’s European Bioinformatics Institute (EMBL...

Read more

Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

2 September 2020

Point-of-care testing – in other words, testing patients as soon as they arrive at the hospital – is essential for enabling healthcare workers to rapidly diagnose patients and direct those who test positive for infection to dedicated wards. A recent study showed that SAMBA II, a new point-of-care PCR test for SARS-CoV-2...

Read more

Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus

28 August 2020

The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19. Read the original article here>

Read more

Unexpected experiences: Mike Weekes describes setting up a full-scale COVID-19 testing facility

27 August 2020

When infectious diseases expert Mike Weekes realised he and colleagues had the know-how to help protect staff, patients and students in a pandemic, they set up a unique testing facility – the first of its kind, they believe, in a UK university – and now a central part of a new public health campaign, Stay Safe Cambridge...

Read more

Cambridge-developed SARS-CoV-2 vaccine receives £1.9million from UK government for clinical trial

26 August 2020

A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9million award from the UK government. Innovate UK, the UK government’s innovation agency, has provided the funding for a collaboration between Cambridge spin-out company...

Read more

Tackling COVID-19: Professor Daniela De Angelis

21 August 2020

Since January this year, Daniela De Angelis and her team have been informing the UK Government’s response to the COVID-19 pandemic. Their real-time model of transmission of the virus is helping to track and predict its course as information accumulates over time. Read the original article here>

Read more

Ageing heart cells offer clues to susceptibility of older people to severe COVID-19

18 August 2020

Genes that play an important role in allowing SARS-CoV-2 to invade heart cells become more active with age, according to research published today in the Journal of Molecular and Cellular Cardiology . Read the original article here>

Read more